written on 20.01.2020

Library > White Papers > Deloitte


Contributed by Deloitte

main_img

The pace and scale of medical and scientific innovation is transforming the biopharma industry. The need for better patient engagement and experience is spurring new business models. Data generated, captured, analysed and used in real-time by innovative medical devices is biopharma’s new currency.

A key differentiator for companies is the extent to which they are able to generate insights and evidence from multiple data sources. Consequently, digital transformation is a strategic imperative. This report outlines how artificial intelligence-enabled technologies will impact the biopharma value chain and accelerate biopharma’s digital transformation.


Related White Papers

Intelligent Drug Discovery: Powered by AI
Failure to Launch: Patent Abuse Blocks Access to Biosimilars for America’s Patients
Lessons Learned from COVID-19
We use cookies to ensure that we give you the best experience on our site. For more info click here